Spain · AEMPS CIMA
EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 09569026
- Form
- COMPRIMIDO RECUBIERTO CON PELÍCULA
- Composition / generic term
- valsartán + amlodipino + hidroclorotiazida
- Source strength
- 160 mg / 5 mg / 25 mg
- Authorisation holder
- Novartis Europharm Limited
- Marketed in source snapshot
- Yes
Source-listed ingredients
- VALSARTAN — 160 mg
- AMLODIPINO BESILATO — 5 mg
- HIDROCLOROTIAZIDA — 25 mg
These values do not establish equivalence or a dose recommendation.
Packages
- EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos
Source and coverage
- Professional information (original source)
- Patient leaflet (original source)
- Official document (original source)
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →